SCHEMBL845300

SCHEMBL845300

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
RHOC P08134 1/20 0.53
RHOA P61586 1/20 0.53
ALDH1A1 P00352 3/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
CNR2 P34972 1/20 0.50
PABPC1 P11940 1/20 0.49
ROCK2 O75116 1/20 0.48
EP300 Q09472 1/20 0.48
CREBBP Q92793 1/20 0.48
PTPN2 P17706 1/20 0.48
PTPN1 P18031 1/20 0.48
KCNH2 Q12809 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31722815 0.90 ALDH1A1 (0.60) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL845591 0.90 HCRTR1 (0.49) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL844934 0.88 RHOC (0.51) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL845297 0.87 RHOC (0.48) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL13272445 0.86 HSD11B1 (0.55) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL845229 0.85 RHOC (0.48) CYP2C9CYP2C19RHOCRHOAALDH1A1
SCHEMBL845008 0.85 ALDH1A1 (0.54) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845349 0.84 HCRTR1 (0.53) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845617 0.84 ALDH1A1 (0.59) CYP2C9CYP2C19ALDH1A1
SCHEMBL873200 0.84 RHOC (0.48) CYP2C9CYP2C19RHOCRHOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed